2026 NPPES data Neurocritical Care Physician NPI 1881221752
Verify on CMS →

Jorge Matta

Neurocritical Care Physician in Bronx, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 389 in Neurocritical Care Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
92
Medicare Part D claims · 22 beneficiaries · Neurocritical Care Physician avg: 291
Industry payments
$57.7
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Jorge Matta filed 92 Medicare Part D claims in 2024 as a Neurocritical Care Physician in Bronx, New York.

92
Part D claims, 2024
$57.7
industry payments (Sunshine Act)
≥0th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Jorge Matta

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1881221752), first enumerated 03/23/2020.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 92 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Industry payment transparency

    $57.7 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Jorge Matta's individual license status. Verify directly with the state medical board.

    Source: NYSBPMC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1881221752 · Neurocritical Care Physician

NPI-10 · ENUM-RECENT · TAX-TRACE · RX-TRACE · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1881221752
  • ENUM-RECENT 2020
  • TAX-TRACE 389
  • RX-TRACE 92
  • BOOK-THIN 34 in New York
  • PHOTO-ENUM Nicholas Asher · 2020

Jorge Matta's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

92 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board-eligible specialty (heuristic, not verified)

Jorge Matta practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Jorge Matta?

Quality data not reported

NPI registry status

Active

Issued 03/23/2020

NPI 1881221752

Primary specialty

Neurocritical Care Physician

Rare

389 US NPIs in this specialty

Medicare Part D claims

92 68% vs specialty avg

2024 prescription claims

Specialty avg: 291

Specialty distribution in New York

How Neurocritical Care Physician compares to other specialties among New York providers

New York providers
Student in an Organized Heal…8%Registered Nurse5.2%Clinical Social Worker4.9%Social Worker4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse4.3%Neurocritical Care Physician0%
Largest specialties in New York (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Neurocritical Care Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

111 E 210TH ST
Bronx, NY 10467

Provider Details

NPI 1881221752
Specialty Neurocritical Care Physician
Gender Male
NPI Issued 03/23/2020

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jorge Matta. Source: openpaymentsdata.cms.gov.

Total received

$58

Largest payer

Teva Pharmaceuticals USA, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Jorge Matta. To verify Jorge Matta's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

92
Total Claims
$5K
Total Drug Cost
22
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
152.467
Total Day Supply
4,489
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
62.3 years
Avg HCC Risk Score
1.35

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

Drug Claims
Lamotrigine
15
Levetiracetam
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurocritical Care Physician Overview

How Jorge Matta fits within the Neurocritical Care Physician landscape nationally.

389
Neurocritical Care Physician Providers in US
45
States with Neurocritical Care Physician
291
Avg Claims per Provider

Jorge Matta's 92 claims are below the specialty average of 291.

Nationwide Neurocritical Care Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Matta, both outside New York so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2020)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Neurocritical Care Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Matta.

One of 34 Neurocritical Care Physician providers enrolled in New York, 5 are shown here.

Compare Neurocritical Care Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Jorge Matta's specialty?
Jorge Matta specializes in Neurocritical Care Physician and practices in Bronx, New York.
How much does Jorge Matta prescribe under Medicare Part D?
In 2024, Jorge Matta wrote 92 Medicare Part D claims totaling $5K in drug costs for 22 beneficiaries.
Where is Jorge Matta located?
Jorge Matta is located at 111 E 210TH ST, Bronx, NY, 10467. Phone: (718) 920-9892.
What is Jorge Matta's NPI number?
Jorge Matta's National Provider Identifier (NPI) is 1881221752, issued on 03/23/2020.
How many Neurocritical Care Physician providers are there in the US?
There are 389 Neurocritical Care Physician providers across 45 states in the US. The average Neurocritical Care Physician provider writes 291 Medicare Part D claims per year.
What drugs does Jorge Matta prescribe most often?
Based on 2024 Medicare Part D data, Jorge Matta's most frequently prescribed drugs include Lamotrigine, Levetiracetam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jorge Matta accept Medicare?
Jorge Matta appears in CMS Medicare data with 92 Part D claims and 22 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jorge Matta's credentials?
Jorge Matta's NPI is 1881221752. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.